|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/451 | (2006.01) |
| A61K 45/06 | (2013.01) | ||
| A61K 31/4704 | (2006.01) | ||
| A61K 31/451 | (2013.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61P 27/06 | (2018.01) |
| (11) | Number of the document | 3419622 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17757261.7 |
| Date of filing the European patent application | 2017-02-24 | |
| (97) | Date of publication of the European application | 2019-01-02 |
| (45) | Date of publication and mention of the grant of the patent | 2024-03-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/019266 |
| Date | 2017-02-24 |
| (87) | Number | WO 2017/147366 |
| Date | 2017-08-31 |
| (30) | Number | Date | Country code |
| 201662299290 P | 2016-02-24 | US |
| (72) |
RUSS, Hermann, Kurt , CH
GEVA, Michal , IL
LAUFER, Ralph , IL
ORBACH, Aric , IL
|
| (73) |
Prilenia Neurotherapeutics Ltd. ,
10 HaMenofim Street, Herzliya 4672561,
IL
|
| (54) | TREATMENT OF NEURODEGENERATIVE EYE DISEASE USING PRIDOPIDINE |
| TREATMENT OF NEURODEGENERATIVE EYE DISEASE USING PRIDOPIDINE |